The stock's rise snapped a three-day losing streak.

ResMed (NYSE:RMD) has had a rough month with its share price down 7.5%. However, stock prices are usually driven by ...

New insights from 30,026 people across 13 markets show the global scale of poor sleep and its impact on health, work, and relationships7 out of 10 employed respondents have called in sick at least onc ...

Principal Financial Group Inc. trimmed its stake in ResMed Inc. (NYSE:RMD – Free Report) by 0.5% during the 4th quarter, Holdings Channel reports. The firm owned 185,788 shares of the medical ...

Equities researchers at Zacks Research raised their Q3 2025 earnings per share estimates for ResMed in a report issued on Wednesday, February 19th. Zacks Research analyst R. Department now anticipates ...

Shares of ResMed Inc. RMD rallied 1.70% to $234.51 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.24% to 6,144.15 and the ...

The global ventilator market, valued at US$3.86 billion in 2023, is forecasted to grow at a robust CAGR of 4.7%, reaching ...

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced upcoming changes to the Company's Board of Directors, including: ...

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced upcoming changes ...

The global high flow nasal cannula market is set to experience a notable downturn over the next decade, with forecasts indicating a decline from USD 1,369.3 million in 2024 to USD 1,063.0 million by ...